DK43489D0 - Immunotoksin og fremgangsmaade til dets fremstilling - Google Patents

Immunotoksin og fremgangsmaade til dets fremstilling

Info

Publication number
DK43489D0
DK43489D0 DK043489A DK43489A DK43489D0 DK 43489 D0 DK43489 D0 DK 43489D0 DK 043489 A DK043489 A DK 043489A DK 43489 A DK43489 A DK 43489A DK 43489 D0 DK43489 D0 DK 43489D0
Authority
DK
Denmark
Prior art keywords
immunotoxin
procedure
preparation
Prior art date
Application number
DK043489A
Other languages
English (en)
Other versions
DK43489A (da
Inventor
Raymond Francis Ebert
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK43489D0 publication Critical patent/DK43489D0/da
Publication of DK43489A publication Critical patent/DK43489A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00Subject matter not provided for in other groups of this subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6819Plant toxins
    • A61K47/6825Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK043489A 1988-02-02 1989-01-31 Immunotoksin og fremgangsmaade til dets fremstilling DK43489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15149988A 1988-02-02 1988-02-02

Publications (2)

Publication Number Publication Date
DK43489D0 true DK43489D0 (da) 1989-01-31
DK43489A DK43489A (da) 1989-08-03

Family

ID=22539046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK043489A DK43489A (da) 1988-02-02 1989-01-31 Immunotoksin og fremgangsmaade til dets fremstilling

Country Status (9)

Country Link
EP (1) EP0327169A3 (da)
JP (1) JPH02152991A (da)
KR (1) KR890013045A (da)
AU (1) AU2883889A (da)
DK (1) DK43489A (da)
FI (1) FI890467A (da)
IE (1) IE890206L (da)
PT (1) PT89584A (da)
ZA (1) ZA89547B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977307A (en) * 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US5182107A (en) * 1989-09-07 1993-01-26 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
US5154924A (en) * 1989-09-07 1992-10-13 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
US6329508B1 (en) 1989-09-07 2001-12-11 Alkermes, Inc. Transferrin receptor reactive chimeric antibodies
US5672683A (en) * 1989-09-07 1997-09-30 Alkermes, Inc. Transferrin neuropharmaceutical agent fusion protein
US5527527A (en) * 1989-09-07 1996-06-18 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
DE4014540A1 (de) * 1990-05-07 1991-11-14 Klaus Dr Tschaikowsky Immunkonjugate zur prophylaxe und therapie von organschaeden bei entzuendlichen prozessen
DE4040954C2 (de) * 1990-12-20 2001-05-17 Max Planck Gesellschaft Verfahren zur Erzeugung von pathogen-resistenten Pflanzen
US6015555A (en) * 1995-05-19 2000-01-18 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
AU609380B2 (en) * 1985-11-29 1991-05-02 Consolidated Pharmaceuticals Limited Ricin-antibody conjugates

Also Published As

Publication number Publication date
EP0327169A2 (en) 1989-08-09
PT89584A (pt) 1989-10-04
AU2883889A (en) 1989-08-03
KR890013045A (ko) 1989-09-21
IE890206L (en) 1989-08-02
JPH02152991A (ja) 1990-06-12
FI890467A (fi) 1989-08-03
EP0327169A3 (en) 1990-07-11
ZA89547B (en) 1989-10-25
FI890467A0 (fi) 1989-02-01
DK43489A (da) 1989-08-03

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO924768L (no) Farmasoeytisk preparat og fremgangsmaate for dets fremstilling
NO931326D0 (no) Komposittprodukt og fremgangsmaate til fremstilling derav
NO882356L (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
DK93992A (da) Depotpraeparat og fremgangsmaade til fremstilling deraf
DK609689A (da) Folielaminat og dets anvendelse
DK116282A (da) Kosmetisk praeparat og fremgangsmaade til dets fremstilling
NO893748D0 (no) Forbedret nedslipbart belegg og fremgangsmaate til dets fremstilling.
DK159288D0 (da) Saccharidblanding og fremgangsmaade til fremstilling deraf
DK733788D0 (da) Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
DK57085A (da) Farmaceutisk praeparat indeholdende methylhydroxyprogesteronacetat og fremgangsmaade til dets fremstilling
DK381886D0 (da) Medicinsk praeparat og fremgangsmaade til dets fremstilling
DK43489D0 (da) Immunotoksin og fremgangsmaade til dets fremstilling
DK330289A (da) Veterinaere indretninger og fremgangsmaade til fremstilling deraf
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
DK50387D0 (da) Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK103889A (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK387389D0 (da) Lipasepraeparat og fremgangsmaade til dets fremstilling
DK338185D0 (da) Antihypertensivt og antianginoest kombinationspraeparat og fremgangsmaade til dets fremstilling
DK129689D0 (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
NO932638L (no) 21-klor-pregnanderivat og fremgangsmaater for dets fremstilling
NO870299D0 (no) Liposom/antrakinon-legemiddelpreparat og fremgangsmaate for dets fremstilling.
DK588887D0 (da) Farmaceutisk praeparat og fremgangsmaade til dets fremstilling

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment